Loading...
Regencell Bioscience Holdings Limited
RGC•NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$695.00
$70.05(11.21%)
Regencell Bioscience Holdings Limited (RGC) Company Profile & Overview
Explore Regencell Bioscience Holdings Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Regencell Bioscience Holdings Limited (RGC) Company Profile & Overview
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Yat-Gai Au
Contact Information
Company Facts
12 Employees
IPO DateJul 16, 2021
CountryHK
Actively Trading